Immunovant Inc.

IMVT ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Nov 21, 2025 8-K
10-Q Nov 10, 2025 10-Q
8-K Nov 10, 2025 8-K
SCHEDULE 13G/A Nov 5, 2025
4 Oct 24, 2025 FORM 4
4 Oct 24, 2025 FORM 4
4 Oct 10, 2025 FORM 4
4 Oct 10, 2025 FORM 4
8-K Sep 3, 2025 8-K
8-K Aug 28, 2025 8-K
10-Q Aug 11, 2025 10-Q
8-K Aug 11, 2025 8-K
4 Jul 30, 2025 FORM 4
8-K Jul 29, 2025 8-K
4 Jul 25, 2025 FORM 4
4 Jul 25, 2025 FORM 4
4 Jul 11, 2025 FORM 4
4 Jul 11, 2025 FORM 4
ARS Jul 9, 2025 ARS
DEFA14A Jul 9, 2025 DEF 14A
DEF 14A Jul 9, 2025 DEF 14A
144 Jun 25, 2025
144 Jun 13, 2025
144 Jun 3, 2025
10-K May 29, 2025 10-K
← Newer Page 4 of 26 · 641 filings Older →